Uganda Lands First Batch of Lenacapavir HIV Prevention Injectable
Uganda takes a major leap in HIV prevention with the arrival of 19,200 doses of Lenacapavir, a twice-yearly injectable drug backed by the Global Fund. Set for distribution to high-risk areas starting March 2026, the highly effective PrEP option targets vulnerable groups to help curb the epidemic affecting over 1.5 million Ugandans. In a pivotal … Read more
